Health & Medicine

STAT+: FDA approves Colorado's plan to import cheaper drugs from Canada

26 sec read6 views0 listens

The FDA has approved Colorado's plan to import cheaper prescription drugs from Canada, following Florida’s lead. This move aims to alleviate high drug costs for residents but faces challenges such as opposition from the Canadian pharmaceutical industry and concerns about disrupting Canada's drug supply. Developers and tech professionals should monitor how these state programs evolve and address logistical hurdles.

Read the full article at STAT News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

Merck, Protillion Launch AI Drug Discovery Collaboration with Up-to-$510M in Milestone Payments

Merck has partnered with Protillion Biosciences to accelerate drug discovery through a collaboration potentially worth up to $510 million. This initiative leverages Protillion's AI-driven "lab-in-the-loop" platform, combining extensive wet-lab data w...

Ali Nemati

Biotech & Pharma1 day ago24 sec read

ZoBio Introduces DNA-Encoded Library Service for Exploratory Drug Discovery Programs

ZoBio has launched a comprehensive DNA-Encoded Library (DEL) discovery service to aid in the identification of drug targets that are difficult or novel. This integrated platform combines multiple techniques, including protein production, biophysical ...

Ali Nemati

Biotech & Pharma2 days ago28 sec read

StockWatch: Parabilis Medicines Makes Wall Street History with $770.5M IPO

Parabilis Medicines achieved a record-breaking $770.5 million IPO, the largest ever for a drug developer, with its stock experiencing a significant initial jump. This event is highly relevant for developers and professionals in the biotech and pharma...

Ali Nemati

Biotech & Pharma4 days ago33 sec read

SonoThera Raises $125M to Develop Ultrasound-Mediated Genetic Medicines

SonoThera has secured $125 million in Series B financing to advance its ultrasound-mediated genetic medicine platform toward clinical trials. This development is significant for the biotech sector because the proprietary RIPPLE and PORE technologies ...

Ali Nemati

Biotech & Pharma4 days ago32 sec read

STAT+: Pharmalittle: We're reading about a discontinued cancer drug, a Novo security breach, and more

The nonprofit Blood Cancer United has acquired the remaining supplies and investigational rights for the discontinued drug Luvelta to continue providing it to children with rare blood cancers. This unusual move highlights a critical shift in the phar...

Ali Nemati

STAT+: FDA approves Colorado's plan to import cheaper drugs from Canada

Related Articles

Merck, Protillion Launch AI Drug Discovery Collaboration with Up-to-$510M in Milestone Payments

ZoBio Introduces DNA-Encoded Library Service for Exploratory Drug Discovery Programs

StockWatch: Parabilis Medicines Makes Wall Street History with $770.5M IPO

SonoThera Raises $125M to Develop Ultrasound-Mediated Genetic Medicines

STAT+: Pharmalittle: We're reading about a discontinued cancer drug, a Novo security breach, and more